Seoul hotel scene heats up as luxury chains, global funds move in
Fueled by a surge in the number of visitors, Seoul's hotel scene is growing more vibrant, drawing in luxury hotel brands and foreign investors looking for a bite of the booming market.
Just two or three years ago, many hotel properties had been either converted into office space or closed altogether due to the impact of the COVID-19 pandemic. Now, with inbound tourism rebounding, hotels are attracting renewed attention.
According to data released by the Korea Tourism Organization on July 31, a total of 8.83 million foreign visitors came to Korea between January and June, up 1.12 million from the same period last year. The figure marks a 104 percent recovery from the pre-pandemic level in 2019.
An increasing number of top-tier luxury hotel brands are looking to establish a presence in Seoul.
Rosewood Seoul is set to open at The Parkside Seoul, a development occupying the former site of the United Nations Command in central Seoul in 2027, while Capella Hotels & Resorts, a Singapore-based hospitality group recognized for its ultra-luxury positioning, will introduce Capella Residences Seoul in southern Seoul in the same year.
Though Korea continues to lack an Aman property -- renowned for its ultra-luxury offerings -- Aman Group is set to make its first foray into Korea through its second brand, Janu, with two upcoming properties: one in Seoul and another on Jeju Island in 2027. Korea will become Janu's sixth global destination and its second in Northeast Asia following Tokyo.
Although Janu Seoul was initially expected to be developed at a site near Seoul Station, the plan has fallen through. The property is now likely to be located in Cheongdam, an affluent district in southern Seoul.
Instead, a Mandarin Oriental hotel will step into the Seoul Station development site by 2029, becoming the brand's first location here.
The Ritz-Carlton, a top-tier franchise under hotel giant Marriott International, is set to open at the redeveloped Millennium Hilton Seoul site in central Seoul by 2031.
'Seoul was once said to lack true luxury hotels, but its luxury hospitality landscape is now evolving rapidly,' an official from a local real estate asset manager said.
'This trend is fueled by the city's appeal to both international visitors and the affluent domestic population.'
Mid-scale deals surge
Along with rising demand for accommodation, four-star properties are seeing an increase in foreign investor interest as well.
The improved profitability of mid-range and budget hotels could be the main driver behind the appeal. A recent report by global real estate services firm JLL showed that revenue per available room at such hotels in Seoul rose 23.4 percent last year from a year earlier, outpacing the 14.4 percent growth seen in luxury hotels.
'Foreign investors are lining up to inquire about investing in local hotel properties,' said a banker specializing in offshore investments.
'While foreign investors have traditionally focused on high-end hotels given their scale of investments, they are now expanding their interest to smaller, mid-scale properties as well.'
In July, Goldman Sachs co-acquired the Mercure Ambassador Hotel Hongdae for 262 billion won ($187 million) with local asset manager JB Asset Management. The four-star hotel located in the vibrant Hongdae district in western Seoul marks the equity giant's inaugural hotel investment in Korea.
Earlier this year, Singapore's sovereign wealth fund GIC was selected as the preferred bidder to acquire three properties operated by Glad Hotel & Resort -- Glad Yeouido, Glad Gangnam Coex Center and Maison Glad Jeju -- in a deal estimated at a total of 600 billion won ($437 million). The Glad brand, under the wings of local builder DL Group, is positioned in the mid-scale segment.
'Visitor arrivals continue to recover strongly, with the value of existing hotels on an upward trend due to limited new supply and rising development costs. These factors will ensure an active hotel acquisition and disposition market,' Clair Choi, head of research at global real estate service firm CBRE, noted in a recent report.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Korea Herald
2 hours ago
- Korea Herald
SK bioscience Discusses Further Collaboration with the Gates Foundation to Advance Global Health
SEONGNAM, South Korea, Aug. 21, 2025 /PRNewswire/ -- SK bioscience, a global innovative vaccine and biotech company committed to promoting human health from prevention to cure, today announced that the company held an exclusive meeting with the Gates Foundation in line with the visit of Bill Gates, Founder and Chair of the Foundation, to Korea to discuss ways to advance global health collaboration. The meeting was held on August 20 in Yeouido, Seoul, and attended by Trevor Mundel, President of Global Health of the Gates Foundation, along with other key foundation representatives, as well as Andrew Chey, Vice-Chairman of SK discovery, and Jaeyong Ahn, CEO of SK bioscience. During the meeting, both organizations reaffirmed their long-standing partnership and commitment to working together on vaccine development and global public health projects. They also explored expanded cooperation in next-generation preventive medicines, with an emphasis on R&D for pandemic preparedness. Since 2013, SK bioscience and the Gates Foundation have collaborated on multiple initiatives, including the development of typhoid and pediatric diarrhea vaccines and other antiviral preventive solutions, contributing to global public health. A notable milestone in their collaboration was the successful development and commercialization of SKYCovione in 2022, Korea's first domestically developed COVID-19 vaccine. That year, Bill Gates and Trevor Mundel visited Korea to celebrate the achievement, meeting with Tony Chey, Chairman of SK Group, and Andrew Chey, Vice-Chairman of SK discovery. SK bioscience remains committed to working with global partners to advance public health and expand equitable access to vaccines worldwide. About SK bioscience SK bioscience is an innovative vaccine and biotech company, committed to vaccine development and manufacturing to enable more equitable access to vaccines around the world. Leveraging strengths on cutting-edge technologies, SK bioscience has been dedicated to promoting human health from prevention to cure across the globe. With the cooperation of domestic and international governments, regulatory agencies, healthcare providers, doctors, and medical experts, all of the SK colleagues are passionately committed to providing high-quality vaccines to those who need them and better public healthcare solutions.
Korea Herald
12 hours ago
- Korea Herald
SK Bioscience, Gates Foundation discuss ways to advance global health
Bill Gates expected to meet with SK Group chair for bioscience, energy cooperation SK Bioscience discussed ways to improve global health with the Gates Foundation, the Korean vaccine and biotechnology firm said Thursday. According to SK Bioscience, SK Discovery Vice Chair Chey Chang-won and SK Bioscience CEO Ahn Jae-yong met with key representatives from the Gates Foundation, including Trevor Mundel, president of global health at the Gates Foundation, in Yeouido, Seoul on the previous day. During the meeting, the two sides reaffirmed their long-standing partnership, which dates back to 2013 when they began collaborating on numerous pro-health initiatives, while reiterating their shared commitment to cooperating on vaccine development and public health projects for the world. They also explored ways to expand joint efforts to discover next-generation preventative medicines with an emphasis on research and development for pandemic preparedness. SK Bioscience and the Gates Foundation have worked together on a number of projects, including the development of typhoid and pediatric diarrhea vaccines and other antiviral preventative solutions. They successfully developed and commercialized SKYCovione, Korea's first homemade COVID-19 vaccine, in 2022. In the same year, Bill Gates traveled to Korea to celebrate the achievement as he met with SK Group Chair Chey Tae-won and SK Discovery Vice Chairman Chey Chang-won. Visiting Seoul this week, Gates is reportedly expected to meet with SK Group Chair Chey on Thursday. SK Inc. and SK Innovation invested $250 million in Gates-founded small modular reactor developer TerraPower in 2022. Chey and Gates are likely to discuss cooperation in bioscience and energy. The Research Investment for Global Health Technology, or RIGHT, Foundation announced that it held a meeting with the Gates Foundation on Wednesday as well as Korean companies — Bioneer, EuBiologics, LG Chem, Noul, SD Biosensor, SK Bioscience and QuadMedicine — to share the Gates Foundation's global health investments and Korean companies' development progress of vaccines, medicines and diagnosis devices. The RIGHT Foundation was established by Korea's Ministry of Health and Welfare, the Gates Foundation and Korean companies as a non-profit organization aimed at improving health fairness of infectious diseases in mid- to low-income nations in 2018. So far, it has provided 118.9 billion won ($85 million) in support for 73 vaccine, medicine and diagnostic device R&D projects in collaboration with 110 partners.
Korea Herald
12 hours ago
- Korea Herald
Seoul hotel scene heats up as luxury chains, global funds move in
Rosewood, Mandarin Oriental, Ritz-Carlton plan openings while Goldman Sachs, GIC target mid-scale deals Fueled by a surge in the number of visitors, Seoul's hotel scene is growing more vibrant, drawing in luxury hotel brands and foreign investors looking for a bite of the booming market. Just two or three years ago, many hotel properties had been either converted into office space or closed altogether due to the impact of the COVID-19 pandemic. Now, with inbound tourism rebounding, hotels are attracting renewed attention. According to data released by the Korea Tourism Organization on July 31, a total of 8.83 million foreign visitors came to Korea between January and June, up 1.12 million from the same period last year. The figure marks a 104 percent recovery from the pre-pandemic level in 2019. An increasing number of top-tier luxury hotel brands are looking to establish a presence in Seoul. Rosewood Seoul is set to open at The Parkside Seoul, a development occupying the former site of the United Nations Command in central Seoul in 2027, while Capella Hotels & Resorts, a Singapore-based hospitality group recognized for its ultra-luxury positioning, will introduce Capella Residences Seoul in southern Seoul in the same year. Though Korea continues to lack an Aman property -- renowned for its ultra-luxury offerings -- Aman Group is set to make its first foray into Korea through its second brand, Janu, with two upcoming properties: one in Seoul and another on Jeju Island in 2027. Korea will become Janu's sixth global destination and its second in Northeast Asia following Tokyo. Although Janu Seoul was initially expected to be developed at a site near Seoul Station, the plan has fallen through. The property is now likely to be located in Cheongdam, an affluent district in southern Seoul. Instead, a Mandarin Oriental hotel will step into the Seoul Station development site by 2029, becoming the brand's first location here. The Ritz-Carlton, a top-tier franchise under hotel giant Marriott International, is set to open at the redeveloped Millennium Hilton Seoul site in central Seoul by 2031. 'Seoul was once said to lack true luxury hotels, but its luxury hospitality landscape is now evolving rapidly,' an official from a local real estate asset manager said. 'This trend is fueled by the city's appeal to both international visitors and the affluent domestic population.' Mid-scale deals surge Along with rising demand for accommodation, four-star properties are seeing an increase in foreign investor interest as well. The improved profitability of mid-range and budget hotels could be the main driver behind the appeal. A recent report by global real estate services firm JLL showed that revenue per available room at such hotels in Seoul rose 23.4 percent last year from a year earlier, outpacing the 14.4 percent growth seen in luxury hotels. 'Foreign investors are lining up to inquire about investing in local hotel properties,' said a banker specializing in offshore investments. 'While foreign investors have traditionally focused on high-end hotels given their scale of investments, they are now expanding their interest to smaller, mid-scale properties as well.' In July, Goldman Sachs co-acquired the Mercure Ambassador Hotel Hongdae for 262 billion won ($187 million) with local asset manager JB Asset Management. The four-star hotel located in the vibrant Hongdae district in western Seoul marks the equity giant's inaugural hotel investment in Korea. Earlier this year, Singapore's sovereign wealth fund GIC was selected as the preferred bidder to acquire three properties operated by Glad Hotel & Resort -- Glad Yeouido, Glad Gangnam Coex Center and Maison Glad Jeju -- in a deal estimated at a total of 600 billion won ($437 million). The Glad brand, under the wings of local builder DL Group, is positioned in the mid-scale segment. 'Visitor arrivals continue to recover strongly, with the value of existing hotels on an upward trend due to limited new supply and rising development costs. These factors will ensure an active hotel acquisition and disposition market,' Clair Choi, head of research at global real estate service firm CBRE, noted in a recent report.
